Evidence map›Paper›PMID 38454797›Full record

ArticleThe Journal of clinical endocrinology and metabolism2024

Prospective Multicenter Registry-Based Study on Thyroid Storm: The Guidelines for Management From Japan Are Useful.

Yasushi Furukawa, Keiko Tanaka, Osamu Isozaki, Atsushi Suzuki, Tadao Iburi, Kumiko Tsuboi, Moritake Iguchi, Naotetsu Kanamoto, Kanshi Minamitani, Shu Wakino and 5 more

Abstract readMulticenter Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Approach to the patient with severe hyperthyroidism-related complications.The Journal of clinical endocrinology and metabolism · 2026
    Review
  4. Article
  5. Approach to the patient with thyroid storm.The Journal of clinical endocrinology and metabolism · 2026
    Review
  6. Article
  7. Article
  8. Plasmapheresis for the treatment of thyroid storm.Endocrinology, diabetes & metabolism case reports · 2025
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yasushi FurukawaFirst Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
Keiko TanakaDepartment of Epidemiology and Public Health, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
Osamu IsozakiWakamatsukawada Clinic, Tokyo 162-0054, Japan.
Atsushi SuzukiDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, Aichi 470-1192, Japan.
Tadao IburiDiabetes, Endocrinology, and Metabolism, Takashimadaira Chuo General Hospital, Tokyo 175-0082, Japan.
Kumiko TsuboiDivision of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine, Tokyo 143-8540, Japan.
Moritake IguchiDepartment of Cardiac Rehabilitation, National Hospital Organization Kyoto Medical Center, Kyoto 612-0861, Japan.
Naotetsu KanamotoDepartment of Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan.
Kanshi MinamitaniDepartment of Pediatrics, Teikyo University Chiba Medical Center, Chiba 299-0112, Japan.
Shu WakinoDepartment of Nephrology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Tetsurou SatohJounan Clinic, Gunma 370-0846, Japan.
Satoshi TeramukaiDepartment of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Eizen KimuraDepartment of Medical Informatics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
Yoshihiro MiyakeDepartment of Epidemiology and Public Health, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
Takashi AkamizuFirst Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.ORCID 0000-0003-4960-8271

Funding

Ministry of Health, Labor and Welfare of Japan
6 · The paper itself

Abstract

contextThe mortality rate in thyroid storm (TS) has been reported to be higher than 10%.

objectiveWe aimed to evaluate the effectiveness of the 2016 guidelines for the management of TS proposed by the Japan Thyroid Association and Japan Endocrine Society.

methodsIn this prospective multicenter registry-based study, patients with new-onset TS were registered in the Research Electronic Data Capture (REDCap), a secure web platform. On day 30 after admission, clinical information and prognosis of each patient were added to the platform. On day 180, the prognosis was described.

resultsThis study included 110 patients with TS. The median of Acute Physiology and Chronic Health Evaluation (APACHE) II score was 13, higher than the score (10) in the previous nationwide epidemiological study (P = .001). Nonetheless, the mortality rate at day 30 was 5.5%, approximately half compared with 10.7% in the previous nationwide survey. Lower body mass index, shock, and lower left ventricular ejection fraction were positively associated with poor prognosis at day 30, while the lack of fever ≥ 38 °C was related to the outcome. The mortality rate in patients with an APACHE II score ≥ 12 for whom the guidelines were not followed was significantly higher than the rate in patients for whom the guidelines were followed (50% vs 4.7%) (P = .01).

conclusionPrognosis seemed better than in the previous nationwide survey, even though disease severity was higher. The mortality rate was lower when the guidelines were followed. Thus, the guidelines are useful for managing TS.

Indexed as

Practice Guidelines as TopicRegistriesThyroid CrisisAdultAgedAPACHEFemaleHumansJapanMaleMiddle AgedPrognosisProspective StudiesepidemiologyGraves diseaseprospectiveREDCapthyroid crisisthyrotoxicosis

Identifiers

PMID38454797
PMCPMC11651683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.